Thomas J. Dull

18.4k citations

50 papers · 15.7k indexed · 8 hit papers · h-index 40

Impact in

Molecular Biology top 0.2%
- Metabolism, Diabetes, and Cancer
- Glycosylation and Glycoproteins Research
- Protein Kinase Regulation and GTPase Signaling
Oncology top 0.5%
- HER2/EGFR in Cancer Research

Papers in

Oncology 17
- HER2/EGFR in Cancer Research 10
Molecular Biology 37
- Chemical Synthesis and Analysis 10
- Glycosylation and Glycoproteins Research 8
- Metabolism, Diabetes, and Cancer 8
- RNA and protein synthesis mechanisms 7
- RNA modifications and cancer 5
- Receptor Mechanisms and Signaling 5

Co-authors: Axel Ullrich Harry F. Noller Jürgen Brosius Lisa M. Coussens Joseph Schlessinger Alane Gray A Ullrich Andrew Gray
Journals: Nature (9 papers)The EMBO Journal (9 papers)Journal of Biological Chemistry (7 papers)Molecular and Cellular Biology (6 papers)Journal of Molecular Biology (3 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Thomas J. Dull

50 papers receiving 14.6k citations

Hit Papers

8 papers align trajectories log scale

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery 1998 · 1.5k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Journal of Virology
1987 Journal of Biological Chemistry
1987 The EMBO Journal
1985 Nature
1984 Nature
1981 Nature
1981 Journal of Molecular Biology
1980 Nature

Peers

Countries citing papers authored by Thomas J. Dull

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Dull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Dull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Dull more than expected).

Fields of papers citing papers by Thomas J. Dull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Dull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Dull. The network helps show where Thomas J. Dull may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas J. Dull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas J. Dull Line = papers co-authored together Thomas J. Dull links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antigen-Specific Cytolysis by Neutrophils and NK Cells Expressing Chimeric Immune Receptors Bearing ζ or γ Signaling Domains The Journal of Immunology ·Margo R. Roberts, Keegan S. Cooke, P Françoise, Kevin M. Smith, Wei Lin, Agnes G. Bailen, Thomas J. Dull, Deborah Farson, Krisztina M. Zsebo, Mitchell Finer	1998	55
2	Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery Journal of Virology ·Romain Zufferey, Thomas J. Dull, Ronald J. Mandel, Antonín Bukovský, 訓由竹川, Luigi Naldini, Didier Trono Hit paper breakdown →	1998	1454
3	Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains. PubMed ·Michelle Roberts, Keegan S. Cooke, 潘云玲, K A Smith, WeiYu Lin, M. Wang, Thomas J. Dull, Deborah Farson, K M Zsebo, M H Finer	1998	67
4	Mosaicism in BCR-ABL protein expression in B cells in chronic meylogenous leukemia International Journal of Cancer ·Eva M. Weissinger, Karin Thalmeier, Thomas J. Dull, M. T. D. Wingate, Bettina Kempkes, Markus Brielmeier, Michael Schumm, Hans‐Jochem Kolb	1996	2
5	Insulin-EGF receptor chimerae mediate tyrosine transphosphorylation and serine/threonine phosphorylation of kinase-deficient EGF receptors Journal of Biological Chemistry ·魏平, Robert Ballotti, Reiner Lammers, Гижа Андрей Владимирович, Thomas J. Dull, Joseph Schlessinger, A. Ullrich, E Van Obberghen	1991	17
6	Molecular Cloning of cDNAs Encoding Bovine and Human Lactoperoxidase DNA and Cell Biology ·Thomas J. Dull, C. T. Uyeda, A. Donny Strosberg, Glenn E. Nedwin, Jeffrey J. Seilhamer	1990	60
7	Characterization of an insulin receptor mutant lacking the subunit processing site. Journal of Biological Chemistry ·Jeffrey F. Williams, Donald A. McClain, Thomas J. Dull, A. Ullrich, Jerrold M. Olefsky	1990	29
8	Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation. Molecular and Cellular Biology ·S. Massoglia, Andrew Gray, Thomas J. Dull, S Munemitsu, Erika Romano, Joseph Schlessinger, A. Ullrich	1990	23
9	HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. The EMBO Journal ·理藤岡, Thomas J. Dull, Irit Lax, Joseph Schlessinger, A. Ullrich	1989	126
10	Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae. The EMBO Journal ·Robert Ballotti, Reiner Lammers, Jean‐Claude Scimeca, Thomas J. Dull, Joseph Schlessinger, A. Ullrich, Ellen Van Obberghen‐Schilling	1989	53
11	Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity Cell ·Morris F. White, James N. Livingston, Jonathan Backer, Vilma Lauris, Thomas J. Dull, Axel Ullrich, C. Ronald Kahn	1988	311
12	Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. The EMBO Journal ·Khashayarsha Khazaie, Thomas J. Dull, Thomas Graf, Joseph Schlessinger, A Ullrich, Hartmut Beug, Björn Vennström	1988	105
13	Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. Journal of Biological Chemistry ·Hiroshi Maegawa, Donald A. McClain, Gary R. Freidenberg, Jerrold M. Olefsky, Mary A. Napier, Terry Lipari, Thomas J. Dull, francisco vinnicius monteiro gomes, A. Ullrich	1988	126
14	Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites. The EMBO Journal ·Annemarie Honegger, Thomas J. Dull, F. Bellot, E Van Obberghen, Daniele Szapary, Albrecht Schmidt, A. Ullrich, Joseph Schlessinger	1988	120
15	Tissue-Specific and Developmentally Regulated Transcription of the Insulin-Like Growth Factor 2 Gene DNA ·Alane Gray, Albert W. Tam, Thomas J. Dull, Joel S. Hayflick, John E. Pintar, Webster K. Cavenee, Alex Koufos, Axel Ullrich	1987	139
16	Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. The EMBO Journal ·Yosef Yarden, Wun-Jing Kuang, Teresa L. Yang‐Feng, Lisa M. Coussens, S Munemitsu, Thomas J. Dull, Wee Yang Gelles‐Soh, Joseph Schlessinger, Uta Francke, A. Ullrich Hit paper breakdown →	1987	1386
17	Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes Nature ·A Ullrich, Jeffrey R. Bell, 敏夫河本, Román Herrera, Lilli Petruzzelli, Thomas J. Dull, Andrew Gray, Lisa M. Coussens, Yiwen Liao, Makoto Tsubokawa, Anthony J. Mason, P. H. Seeburg, Carl Grünfeld, O M Rosen, J. Ramachandran Hit paper breakdown →	1985	1917
18	rII cistrons of bacteriophage T4 Journal of Molecular Biology ·David Pribnow, D. Christine Sigurdson, Larry Gold, Britta Swebilius Singer, Carolyn A. Napoli, Jürgen Brosius, Thomas J. Dull, Harry F. Noller	1981	145
19	Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli Plasmid ·Jürgen Brosius, Axel Ullrich, Nahed Ahmed Shawki, Alane Gray, Thomas J. Dull, Robin R. Gutell, Harry F. Noller	1981	425
20	Genetic Variation in the Human Insulin Gene Science ·Axel Ullrich, Thomas J. Dull, Alane Gray, Jürgen Brosius, I Sures	1980	113

About Thomas J. Dull

Thomas J. Dull is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology and Cellular and Molecular Neuroscience, having authored 50 papers that have together received 15.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Chemical Synthesis and Analysis (10 papers), HER2/EGFR in Cancer Research (10 papers), Glycosylation and Glycoproteins Research (8 papers), Metabolism, Diabetes, and Cancer (8 papers), RNA and protein synthesis mechanisms (7 papers), RNA modifications and cancer (5 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Molecular Biology (10.6k citations), Oncology (3.0k citations), Genetics (2.9k citations), Immunology (2.1k citations) and Endocrinology, Diabetes and Metabolism (1.6k citations). Thomas J. Dull has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Axel Ullrich, Harry F. Noller, Jürgen Brosius, Lisa M. Coussens, Joseph Schlessinger, Alane Gray, A Ullrich, Andrew Gray, Yosef Yarden and A. Ullrich. Their work appears in journals such as Nature, The EMBO Journal, Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact